
UiPath, Inc.
- What it sells
- Subscription services is 59% of revenue (fiscal year to Jan 2026), up from 50% two years earlier.
- Growing?
- Yes: revenue up 13% on a year earlier (quarter ended Jul 2026); earnings per share up 2,133% over the last four quarters.
- Expensive?
- EV / revenue 3.3×. EV/revenue below the peer median of 22.9x: cheaper than its peers.
- Analysts?
- 15% of 20 say buy; average 12-month target $15.40, 18% above today's price.
- Risky?
- Much swingier than most large companies: its price swung 63% over the past year (the S&P 500's 14%), and it fell as much as 84% since Nov 2021.
UiPath, Inc. provides the UiPath Platform for Agentic Automation (including RPA, AI agents, and orchestration) used by organizations to automate business processes, typically monetized via subscription software licenses and related support/services.
More about UiPath
The platform includes products such as Studio, Robots, Orchestrator, and Maestro, delivered across cloud and on-premises deployment options.
Market Position
UiPath is a prominent enterprise automation vendor in the RPA/automation software market, differentiating through an end-to-end platform spanning discovery (process/task mining), build (Studio/low-code), run (robots), and orchestration (Maestro/Orchestrator) plus ecosystem distribution via the UiPath Marketplace. It competes with broader workflow/automation suites and RPA-centric peers, with positioning increasingly focused on agentic automation.
How has the stock done?
Over the past month PATH fell 1.7%; the software ETF (IGV) fell 8.8% and the S&P 500 fell 2.7%.
Over the past six months PATH rose 30.9%; the software ETF (IGV) rose 13.4% and the S&P 500 rose 2.6%.
Over the past year PATH fell 8.1%; the software ETF (IGV) fell 7.6% and the S&P 500 rose 10.8%.
Over five years PATH fell 75.6%; the software ETF (IGV) rose 14.5% and the S&P 500 rose 62.0%.
From Nov 9, 2021 to Apr 10, 2026, the deepest drop from a high since Nov 2021
How much the price swings in a year; the S&P 500's was 14%
When the S&P 500 moves 1%, the stock has moved about 1.0% the same way
Show the earnings releases
| Released | Quarter | Revenue | EPS vs estimate | Stock, day after | 5 days after |
|---|---|---|---|---|---|
| Sep 3, 2026 | ended Jul 2026 | $410M (+13% vs a year earlier) | $0.15 vs $0.15 (in line) | −15.6% | −23.6% |
| May 28, 2026 | ended Apr 2026 | $418M (+17% vs a year earlier) | $0.15 vs $0.16 (missed) | +5.0% | +4.6% |
| Mar 11, 2026 | ended Jan 2026 | $481M (+14% vs a year earlier) | $0.30 vs $0.25 (beat) | −1.9% | +7.4% |
| Dec 3, 2025 | ended Oct 2025 | $411M (+16% vs a year earlier) | $0.16 vs $0.15 (beat) | +29.2% | +30.7% |
| Sep 4, 2025 | ended Jul 2025 | $362M (+14% vs a year earlier) | — | +5.6% | +7.4% |
| May 29, 2025 | ended Apr 2025 | $357M (+6% vs a year earlier) | — | +2.9% | +2.5% |
| Mar 12, 2025 | ended Jan 2025 | $424M (+5% vs a year earlier) | — | −15.1% | −8.0% |
| Dec 5, 2024 | ended Oct 2024 | $355M (+9% vs a year earlier) | — | −3.4% | −7.2% |
| Sep 5, 2024 | ended Jul 2024 | $316M (+10% vs a year earlier) | — | −5.9% | −5.5% |
| May 29, 2024 | ended Apr 2024 | $335M (+16% vs a year earlier) | — | −35.6% | −36.7% |
| Mar 13, 2024 | ended Jan 2024 | $405M (+31% vs a year earlier) | — | −7.7% | −5.4% |
| Nov 30, 2023 | ended Oct 2023 | $326M (+24% vs a year earlier) | — | +26.0% | +17.8% |
| Sep 6, 2023 | ended Jul 2023 | $287M (+19% vs a year earlier) | — | +11.7% | +12.2% |
| May 24, 2023 | ended Apr 2023 | $290M (+18% vs a year earlier) | — | −12.7% | +7.8% |
| Mar 15, 2023 | ended Jan 2023 | $309M (+7% vs a year earlier) | — | +19.9% | +13.0% |
| Dec 1, 2022 | ended Oct 2022 | $263M (+19% vs a year earlier) | — | +16.5% | +5.1% |
| Sep 6, 2022 | ended Jul 2022 | $242M (+24% vs a year earlier) | — | −14.0% | −11.1% |
| Jun 1, 2022 | ended Apr 2022 | $245M (+32% vs a year earlier) | — | +15.1% | +25.1% |
| Mar 30, 2022 | ended Jan 2022 | $290M (+39% vs a year earlier) | — | −31.2% | −32.3% |
| Dec 8, 2021 | ended Oct 2021 | $221M (+50% vs a year earlier) | — | +0.1% | −10.3% |
Change in closing price from the first day shown, or with Price the closing price itself. Prices: Yahoo Finance, to Nov 12, 2026. Dashed lines: the days the company released earnings (its SEC 8-K filings); EPS estimates: Yahoo Finance. The stock's move after a release runs from the last close before its day to the close the day after (or five days after), so a release before the open counts like one after the close.
Is the business growing?
Revenue was $410M in the quarter ended Jul 2026, up 13% from a year earlier.
Show the data
| Quarter ended | Revenue | vs a year earlier |
|---|---|---|
| Oct 2022 | $263M | +19% |
| Jan 2023 | $309M | +7% |
| Apr 2023 | $290M | +18% |
| Jul 2023 | $287M | +19% |
| Oct 2023 | $326M | +24% |
| Jan 2024 | $405M | +31% |
| Apr 2024 | $335M | +16% |
| Jul 2024 | $316M | +10% |
| Oct 2024 | $355M | +9% |
| Jan 2025 | $424M | +5% |
| Apr 2025 | $357M | +6% |
| Jul 2025 | $362M | +14% |
| Oct 2025 | $411M | +16% |
| Jan 2026 | $481M | +14% |
| Apr 2026 | $418M | +17% |
| Jul 2026 | $410M | +13% |
Revenue went from $1.1B in FY23 to $1.6B in FY26; net income from −$328M to $282M.
Show the data
| Fiscal year | Revenue | Net income |
|---|---|---|
| FY23 | $1.1B | −$328M |
| FY24 | $1.3B | −$90M |
| FY25 | $1.4B | −$74M |
| FY26 | $1.6B | $282M |
In the fiscal year to Jan 2026, Subscription services was 59% and Licenses was 38% of revenue; Licenses fell from 48% in the fiscal year to Jan 2024.
Show the data
| Fiscal year | Part | Revenue | Share |
|---|---|---|---|
| FY2024 | Subscription services | $650M | 50% |
| FY2024 | Licenses | $621M | 48% |
| FY2024 | Professional services and other | $37M | 3% |
| FY2025 | Subscription services | $802M | 56% |
| FY2025 | Licenses | $587M | 41% |
| FY2025 | Professional services and other | $41M | 3% |
| FY2026 | Subscription services | $954M | 59% |
| FY2026 | Licenses | $606M | 38% |
| FY2026 | Professional services and other | $50M | 3% |
In the fiscal year to Jan 2026, Americas was 50% and Europe, Middle East, and Africa was 33% of revenue; Asia-Pacific fell from 20% in the fiscal year to Jan 2024.
Show the data
| Fiscal year | Part | Revenue | Share |
|---|---|---|---|
| FY2024 | Americas | $632M | 48% |
| FY2024 | Europe, Middle East, and Africa | $416M | 32% |
| FY2024 | Asia-Pacific | $260M | 20% |
| FY2025 | Americas | $695M | 49% |
| FY2025 | Europe, Middle East, and Africa | $458M | 32% |
| FY2025 | Asia-Pacific | $277M | 19% |
| FY2026 | Americas | $799M | 50% |
| FY2026 | Europe, Middle East, and Africa | $528M | 33% |
| FY2026 | Asia-Pacific | $284M | 18% |
A year earlier $0.00
Diluted, from SEC filings
Quarters: UiPath, Inc.'s SEC filings, named by the month they end. Fiscal years: UiPath, Inc.'s annual reports to the SEC.
How it makes money
Of every $100 in revenue, $17.5 ends up as net income. Net margin rose from −31.0% to 17.5% over the past 3 years.
Show the data
| Quarter ended | Gross | Operating | Net |
|---|---|---|---|
| Oct 2022 | 83.7% | −25.5% | −22.0% |
| Jan 2023 | 84.5% | −14.6% | −9.0% |
| Apr 2023 | 84.9% | −16.0% | −11.0% |
| Jul 2023 | 82.9% | −27.0% | −21.0% |
| Oct 2023 | 84.7% | −17.1% | −9.7% |
| Jan 2024 | 86.8% | 3.7% | 8.4% |
| Apr 2024 | 83.5% | −14.8% | −8.6% |
| Jul 2024 | 80.0% | −32.7% | −27.2% |
| Oct 2024 | 82.0% | −12.2% | −3.0% |
| Jan 2025 | 84.8% | 7.9% | 12.2% |
| Apr 2025 | 82.1% | −4.6% | −6.3% |
| Jul 2025 | 82.2% | −5.6% | 0.4% |
| Oct 2025 | 83.3% | 3.2% | 48.4% |
| Jan 2026 | 84.6% | 16.7% | 21.7% |
| Apr 2026 | 81.6% | 6.7% | 5.4% |
| Jul 2026 | 80.4% | 7.7% | 8.8% |
Circled: Oct 2025 (net 48.4%, operating 3.2%). Net margin is usually about 5 points above operating margin; in that quarter something below operating income (a tax charge or benefit, a gain or loss on investments, a write-down) moved it, not the business itself.
Roughly flat over 3 years
+36.4 pts over 3 years
+48.5 pts over 3 years
Each margin is that line of the income statement divided by revenue. Fiscal year: UiPath, Inc.'s annual reports to the SEC; quarters: SEC filings.
Growth and margins together
Rule of 40 score 34.5 (growth 13.4% + FCF margin 21.1%): middling, short of the 40 line. Stock pay is 13.6% of revenue; counted as a cost, it brings the FCF margin down to 7.5%.
A rule of thumb for software: revenue growth plus free-cash-flow margin should reach 40. From 20 to 40 is middling, under 20 weak. The line is 40. Microsoft for comparison.
Cash flow adds stock pay back because no cash leaves the company, but shareholders pay for it through new shares. Counting it as a cost shows the margin as if staff were paid in cash.
UiPath trades at 3.3× revenue on 13.4% growth. PLTR grows fastest of its peers, 95.9%, and costs 55.3×.
Show the data
| Company | Revenue growth | EV / revenue |
|---|---|---|
| PATH | 13.4% | 3.3× |
| MSFT | 18.8% | 11.4× |
| PLTR | 95.9% | 55.3× |
| ORCL | 29.6% | 7.3× |
| PANW | 34.5% | 22.9× |
| CRWD | 25.8% | 42.8× |
Growth: revenue in the quarter ended Jul 2026 against the quarter ended Jul 2025. FCF margin: operating cash flow minus capex, over revenue, for the 4 quarters ended Jul 2026. From SEC filings.
Customers and suppliers
In its latest annual report UiPath buys from One Vanderbilt Owner.
Suppliers
Changes since the previous annual report (10-K filed Mar 24, 2025)
Show the filing's words
| Company | Role | In the filing's words |
|---|---|---|
| One Vanderbilt Owner | supplier | “Lease Agreement dated as of September 24, 2021 between UiPath, Inc. and One Vanderbilt Owner LLC” |
Only the companies UiPath names in its 10-K filed Mar 25, 2026 (SEC). The supply chain joins the latest annual reports of the companies on it and the 8-Ks they filed since: a link shows when either side's report names the other, so it grows as more reports are read. Hover a name for the filing's own words.
Is it expensive?
EV/revenue of 3.3x, below the peer median of 22.9x.
EV/revenue below the peer median of 22.9x: cheaper than its peers.
Show the data
| Company | EV / revenue |
|---|---|
| PLTR · Palantir Technologies Inc. | 55.3× |
| CRWD · CrowdStrike Holdings, Inc. | 42.8× |
| PANW · Palo Alto Networks, Inc. | 22.9× |
| MSFT · Microsoft Corporation | 11.4× |
| ORCL · Oracle Corporation | 7.3× |
| PATH · UiPath, Inc. | 3.3× |
Compared on enterprise value (market cap plus debt minus cash) per $1 of revenue: for companies that reinvest what they earn or borrow to grow (software, AI data centers), P/E can mislead.
What analysts expect
The average analyst price target is $15.40, 18% above the current price; 15% of 20 analysts rate it a buy; earnings beat estimates in 2 of the last 4 quarters.
Buy or Strong Buy: 3 analysts (15%). Sell or Strong Sell: 2.
Over the past year the average of the analysts' latest price targets went from $14.09 to $15.57 (+11%), while PATH went from $14.09 to $13.10 (−7%). In the past three months targets were raised 13 times and cut 7 times. 1 upgrade and 2 downgrades over the year; the latest: DA Davidson moved it to Underperform from Neutral on Sep 28, 2026.
Show every change
| Date | Firm | Change | Rating | Target |
|---|---|---|---|---|
| Sep 28, 2026 | DA Davidson | Downgrade | Underperform, was Neutral | $10.00 |
| Sep 25, 2026 | UBS | Target cut | Neutral | $14.00, was $15.00 |
| Sep 24, 2026 | BMO Capital | Target cut | Market Perform | $15.00, was $18.00 |
| Sep 24, 2026 | Canaccord Genuity | Target cut | Hold | $14.00, was $17.00 |
| Sep 24, 2026 | TD Cowen | Target cut | Hold | $15.00, was $16.00 |
| Sep 23, 2026 | Truist Securities | Target cut | Hold | $14.00, was $17.00 |
| Sep 23, 2026 | TD Cowen | Target kept | Hold | $16.00 |
| Sep 23, 2026 | RBC Capital | Target cut | Sector Perform | $15.00, was $17.00 |
| Sep 23, 2026 | UBS | Target cut | Neutral | $15.00, was $19.00 |
| Sep 23, 2026 | Needham | Target kept | Buy | $22.00 |
| Sep 8, 2026 | Citigroup | Began coverage | Buy | $23.00 |
| Sep 4, 2026 | Barclays | Target raised | Equal-Weight | $17.00, was $14.00 |
| Sep 4, 2026 | Truist Securities | Target raised | Hold | $17.00, was $12.00 |
| Sep 4, 2026 | Mizuho | Target raised | Neutral | $14.00, was $12.00 |
| Sep 4, 2026 | B of A Securities | Target raised | Underperform | $15.00, was $13.00 |
| Sep 4, 2026 | BMO Capital | Target raised | Market Perform | $18.00, was $13.00 |
| Sep 4, 2026 | Wells Fargo | Target raised | Equal-Weight | $15.00, was $13.00 |
| Sep 4, 2026 | RBC Capital | Target raised | Sector Perform | $17.00, was $15.00 |
| Sep 4, 2026 | TD Cowen | Target raised | Hold | $16.00, was $13.00 |
| Sep 4, 2026 | DA Davidson | Target raised | Neutral | $16.00, was $12.00 |
| Sep 4, 2026 | Canaccord Genuity | Downgrade | Hold, was Buy | $17.00, was $15.00 |
| Sep 3, 2026 | Needham | Target raised | Buy | $22.00, was $15.00 |
| Aug 31, 2026 | UBS | Target raised | Neutral | $19.00, was $12.00 |
| Aug 14, 2026 | RBC Capital | Target raised | Sector Perform | $15.00, was $12.00 |
| Jun 29, 2026 | UBS | Target cut | Neutral | $12.00, was $13.00 |
| Jun 1, 2026 | BMO Capital | Target cut | Market Perform | $13.00, was $14.00 |
| May 29, 2026 | DA Davidson | Target cut | Neutral | $12.00, was $13.00 |
| May 29, 2026 | B of A Securities | Target raised | Underperform | $13.00, was $12.00 |
| May 29, 2026 | Morgan Stanley | Target cut | Equal-Weight | $15.00, was $17.00 |
| May 29, 2026 | Needham | Target kept | Buy | $15.00 |
| Mar 16, 2026 | BMO Capital | Target cut | Market Perform | $14.00, was $17.00 |
| Mar 12, 2026 | UBS | Target cut | Neutral | $13.00, was $17.00 |
| Mar 12, 2026 | Canaccord Genuity | Target cut | Buy | $15.00, was $19.00 |
| Mar 12, 2026 | Truist Securities | Target cut | Hold | $12.00, was $17.00 |
| Mar 12, 2026 | TD Cowen | Target cut | Hold | $13.00, was $16.00 |
| Mar 12, 2026 | B of A Securities | Target cut | Underperform | $12.00, was $14.00 |
| Mar 12, 2026 | DA Davidson | Target cut | Neutral | $13.00, was $15.00 |
| Mar 12, 2026 | Wells Fargo | Target cut | Equal-Weight | $13.00, was $14.00 |
| Mar 12, 2026 | Mizuho | Target cut | Neutral | $12.00, was $15.00 |
| Mar 12, 2026 | Morgan Stanley | Target cut | Equal-Weight | $17.00, was $19.00 |
| Mar 12, 2026 | Needham | Upgrade | Buy, was Hold | $15.00 |
| Jan 12, 2026 | Barclays | Target raised | Equal-Weight | $18.00, was $16.00 |
| Jan 5, 2026 | RBC Capital | Target cut | Sector Perform | $17.00, was $19.00 |
| Dec 10, 2025 | RBC Capital | Target raised | Sector Perform | $19.00, was $16.00 |
| Dec 9, 2025 | Morgan Stanley | Target raised | Equal-Weight | $19.00, was $15.00 |
| Dec 5, 2025 | DA Davidson | Target raised | Neutral | $15.00, was $12.00 |
| Dec 4, 2025 | Barclays | Target raised | Equal-Weight | $16.00, was $14.00 |
| Dec 4, 2025 | BMO Capital | Target raised | Market Perform | $17.00, was $13.00 |
| Dec 4, 2025 | RBC Capital | Target raised | Sector Perform | $16.00, was $14.00 |
| Dec 4, 2025 | Evercore ISI Group | Target raised | In-Line | $17.00, was $15.00 |
| Dec 4, 2025 | Mizuho | Target raised | Neutral | $15.00, was $14.00 |
| Dec 4, 2025 | Canaccord Genuity | Target raised | Buy | $19.00, was $15.00 |
| Dec 4, 2025 | Wells Fargo | Target raised | Equal-Weight | $14.00, was $12.00 |
| Dec 4, 2025 | Needham | Rating kept | Hold | — |
Show the data
| Quarter | Estimate | Reported | Surprise |
|---|---|---|---|
| Oct ’25 | $0.15 | $0.16 | +6.7% |
| Jan ’26 | $0.25 | $0.30 | +20.0% |
| Apr ’26 | $0.16 | $0.15 | −6.3% |
| Jul ’26 | $0.15 | $0.15 | 0.0% |
The day after each of these reports the stock moved +29.2% (Oct 2025, beat); −1.9% (Jan 2026, beat); +5.0% (Apr 2026, missed); −15.6% (Jul 2026, in line).
For the quarter ending Oct 2026 (UiPath reports on Dec 3, 2026), analysts expect adjusted earnings of $0.19 a share, 20% more than the $0.16 of a year earlier, and revenue of $443M, up 8% on a year earlier. For the fiscal year ending Jan 2027, they expect adjusted earnings of $0.79 a share, and revenue of $1.8B, up 11% on the year before.
Adjusted. Oct 2025: $0.16; range $0.16 to $0.22; 19 analysts
Oct 2025: $411M; range $442M to $444M; 17 analysts
Adjusted. Range $0.71 to $0.86; 21 analysts
The year to Jan 2026: $1.6B; range $1.8B to $1.8B; 19 analysts
Show the data
| Period | Figure | Expected | Low to high | Analysts | A year earlier | Change |
|---|---|---|---|---|---|---|
| Quarter ending Oct 2026, results Dec 3, 2026 | EPS (adjusted) | $0.19 | $0.16 to $0.22 | 19 | $0.16 (Oct 2025) | +20% |
| Quarter ending Oct 2026, results Dec 3, 2026 | Revenue | $443M | $442M to $444M | 17 | $411M (Oct 2025) | +8% |
| Quarter ending Jan 2027 | EPS (adjusted) | $0.30 | $0.25 to $0.34 | 20 | $0.30 (Jan 2026) | −1% |
| Quarter ending Jan 2027 | Revenue | $521M | $519M to $527M | 16 | $481M (Jan 2026) | +8% |
| Year ending Jan 2027 | EPS (adjusted) | $0.79 | $0.71 to $0.86 | 21 | — | — |
| Year ending Jan 2027 | Revenue | $1.8B | $1.8B to $1.8B | 19 | $1.6B (year to Jan 2026) | +11% |
| Year ending Jan 2028 | EPS (adjusted) | $0.92 | $0.75 to $1.11 | 21 | $0.79 (expected, year to Jan 2027) | +17% |
| Year ending Jan 2028 | Revenue | $1.9B | $1.9B to $2.0B | 20 | $1.8B (expected, year to Jan 2027) | +8% |
Targets, ratings and earnings estimates: Yahoo Finance. Rating and target changes: Yahoo Finance's list of upgrades and downgrades. The average target on each day is the average of every listed firm's latest target set in the 180 days before it, so it counts fewer analysts than the average target above, and the band is the middle half of those targets (a quarter of the firms are above it, a quarter below); a target set before a stock split is divided by the split. Expected figures: the average of the analysts' estimates (Yahoo Finance). Their EPS is adjusted, as analysts estimate it, so it is set against the adjusted EPS Yahoo reports for the same quarters, not the GAAP EPS of the growth and valuation sections; revenue against the SEC filings. No change is given against a quarter whose reported EPS was more than 50% off its own estimate (often a one-off gain or charge), nor against a year that counts one. Each estimate is pinned to its fiscal period by the report date or the period's end, and one that cannot be is left out.
Where the cash goes
Generated $363M in free cash flow over the year, of which $269M went back to shareholders (dividends plus buybacks), leaving $94M in the company.
Show the data
| Line | Amount |
|---|---|
| Op. cash flow | $373M |
| Capex | −$10M |
| Free cash flow | $363M |
| Dividends | — |
| Buybacks | −$269M |
| Cash retained | $94M |
For every $100 of market cap, the company generates about $5.3 in free cash flow a year.
No dividend today; cash goes to growth and share buybacks.
Dividends plus buybacks over the last four quarters: for every $100 of market cap, about $3.9 went back to shareholders.
Show the data
| Quarter ended | Free cash flow | Dividends | Buybacks |
|---|---|---|---|
| Oct 2023 | $41M | — | $53M |
| Jan 2024 | $142M | — | $50M |
| Apr 2024 | $99M | — | $22M |
| Jul 2024 | $45M | — | $197M |
| Oct 2024 | $23M | — | $163M |
| Jan 2025 | $139M | — | $9.3M |
| Apr 2025 | $106M | — | $228M |
| Jul 2025 | $42M | — | $102M |
| Oct 2025 | $25M | — | $0 |
| Jan 2026 | $179M | — | $0 |
| Apr 2026 | $129M | — | $244M |
| Jul 2026 | $29M | — | $25M |
UiPath had 523M diluted shares in the quarter ended Jul 2026, 3.7% fewer than a year earlier, and 0.1% fewer each year on average since Jul 2021. It spent $269M on buybacks over the last four quarters.
Show the data
| Quarter ended | Diluted shares |
|---|---|
| Jul 2021 | 527M |
| Oct 2021 | 532M |
| Apr 2022 | 542M |
| Jul 2022 | 546M |
| Oct 2022 | 550M |
| Apr 2023 | 558M |
| Jul 2023 | 563M |
| Oct 2023 | 567M |
| Apr 2024 | 570M |
| Jul 2024 | 568M |
| Oct 2024 | 551M |
| Apr 2025 | 548M |
| Jul 2025 | 543M |
| Oct 2025 | 539M |
| Apr 2026 | 528M |
| Jul 2026 | 523M |
Free cash flow: operating cash flow minus capital spending on property, plant and equipment, from SEC filings, for the last 4 quarters and by quarter. Shares: each quarter's diluted weighted average as filed with the SEC, since the stock's listing and its latest split.
Financial health
Current ratio 2.5, no pressure to repay short-term debt; debt-to-equity 0.0, debt is very low and the balance sheet is solid.
Assets that can be turned into cash soon are 2.5x what is owed within a year. 1.5 or higher is comfortable; below 1 needs watching.
For every $1 of shareholder funds, there is $0.0 of debt (leases not counted). The higher the number, the more pressure when the economy weakens.
Cash and short-term investments of $1.5B and no debt. Lease obligations of $81M are not counted: they are rent owed, not money borrowed. It also holds $217M of long-term investments, all of them securities it could sell.
Latest fiscal year balance sheet. Source: Yahoo Finance.
Who holds it
In the filings of 5 funds whose copy leaves PATH out (on the exchange, not in the app yet): Coatue Management, Canada Pension Plan Investment Board, Swiss National Bank, Norges Bank, Mirae Asset Global Investments.
What did the funds Hunch tracks do?
Of the 83 funds whose 13F filings Hunch reads, 6 held PATH at the end of their latest quarter (for most, Q2 2026). Over that quarter 1 added shares, 5 cut and 3 sold all. The largest of them is Renaissance Technologies, 18.56M shares worth $238M at Sep 30, 2026, 422.3% more than a quarter earlier.
Over their latest quarter
3 of them sold all
Show every fund
| Fund | Quarter | Shares | Value | Change in shares | Change | Filed |
|---|---|---|---|---|---|---|
| Renaissance Technologies | Q3 2026 | 18.56M | $238M | +15.01M | +422% | Nov 12, 2026 |
| Norges Bank | Q2 2026 vs Q4 2025 | 4.79M | $52.0M | −2.55M | −35% | Aug 12, 2026 |
| Coatue Management | Q2 2026 | 1.96M | $21.3M | −308,192 | −14% | Aug 14, 2026 |
| Canada Pension Plan Investment Board | Q2 2026 | 1.02M | $11.1M | −1.70M | −63% | Aug 14, 2026 |
| Swiss National Bank | Q3 2026 | 802,300 | $10.3M | −4,000 | −0.5% | Nov 12, 2026 |
| Tudor Investment Corp Et Al | Q2 2026 | 0 | — | −207,999 | Sold all | Aug 14, 2026 |
| Bridgewater Associates | Q2 2026 | 0 | — | −37,242 | Sold all | Aug 14, 2026 |
| Nomura Holdings | Q2 2026 | 0 | — | −26,928 | Sold all | Aug 14, 2026 |
| Mirae Asset Global Investments | Q3 2026 | 2,743 | $35K | −256,755 | −99% | Nov 3, 2026 |
From the 13F filings of the 83 funds Hunch tracks, not of every institution: each fund's shares of PATH at its latest quarter end against the quarter before, as filed (long positions only, options left out), the quarter before put on the latest quarter's share count across a split. A fund files 45 days after its quarter ends, so some have a newer quarter than others. Value is at the quarter end. Norges Bank filed its 13F for Q1 2026 confidentially, with no holdings made public, so its row compares Q2 2026 with Q4 2025.
Are insiders buying or selling?
Officers and directors sold $86.0M of PATH on the open market in the 12 months to Nov 12, 2026; none bought. 100% of the sales were made under 10b5-1 plans, set up in advance. The largest was Daniel Dines (CEO and Chairman; director), who sold $77.6M in 33 sales.
45 sales
0 purchases
Share of the sales' value
Show every trade
| Date | Insider | Role | Trade | Shares | Price | Value | Filed |
|---|---|---|---|---|---|---|---|
| Nov 9, 2026 | Brad Brubaker | Chief Legal & Admin Officer | Sale (10b5-1 plan) | 27,404 | $13.03 | $357K | Nov 10, 2026 |
| Oct 22, 2026 | Raghavendra Malpani | CPO & CTO | Sale (10b5-1 plan) | 29,565 | $14.00 | $414K | Oct 26, 2026 |
| Oct 16, 2026 | Daniel Dines | CEO and Chairman; director | Sale (10b5-1 plan) | 1.20M | $12.98 | $15.6M | Oct 19, 2026 |
| Oct 16, 2026 | Daniel Dines | CEO and Chairman; director | Sale (10b5-1 plan) | 47,600 | $13.83 | $658K | Oct 19, 2026 |
| Oct 15, 2026 | Daniel Dines | CEO and Chairman; director | Sale (10b5-1 plan) | 1.25M | $13.44 | $16.8M | Oct 19, 2026 |
| Oct 12, 2026 | Brad Brubaker | Chief Legal & Admin Officer | Sale (10b5-1 plan) | 27,404 | $13.63 | $374K | Oct 13, 2026 |
| Oct 9, 2026 | Raghavendra Malpani | CPO & CTO | Sale (10b5-1 plan) | 29,564 | $13.51 | $399K | Oct 13, 2026 |
| Oct 2, 2026 | Ashim Gupta | COO | Sale (10b5-1 plan) | 66,052 | $13.17 | $870K | Oct 5, 2026 |
| Sep 17, 2026 | Raghavendra Malpani | CPO & CTO | Sale (10b5-1 plan) | 40,464 | $14.00 | $567K | Sep 21, 2026 |
| Sep 16, 2026 | Raghavendra Malpani | CPO & CTO | Sale (10b5-1 plan) | 98,429 | $13.81 | $1.4M | Sep 17, 2026 |
| Sep 11, 2026 | Ashim Gupta | COO | Sale (10b5-1 plan) | 117,339 | $13.85 | $1.6M | Sep 14, 2026 |
| Aug 19, 2026 | Daniel Dines | CEO and Chairman; director | Sale (10b5-1 plan) | 1.40M | $16.07 | $22.5M | Aug 19, 2026 |
| Aug 14, 2026 | Hitesh Ramani | Chief Accounting Officer | Sale (10b5-1 plan) | 25,000 | $16.75 | $419K | Aug 14, 2026 |
| Aug 13, 2026 | Hitesh Ramani | Chief Accounting Officer | Sale (10b5-1 plan) | 25,000 | $16.50 | $412K | Aug 14, 2026 |
| Jan 26, 2026 | Daniel Dines | CEO and Chairman; director | Sale (10b5-1 plan) | 45,000 | $15.01 | $676K | Jan 26, 2026 |
| Jan 23, 2026 | Daniel Dines | CEO and Chairman; director | Sale (10b5-1 plan) | 45,000 | $15.23 | $686K | Jan 26, 2026 |
| Jan 22, 2026 | Daniel Dines | CEO and Chairman; director | Sale (10b5-1 plan) | 45,000 | $15.02 | $676K | Jan 26, 2026 |
| Jan 15, 2026 | Daniel Dines | CEO and Chairman; director | Sale (10b5-1 plan) | 45,000 | $15.38 | $692K | Jan 15, 2026 |
| Jan 14, 2026 | Daniel Dines | CEO and Chairman; director | Sale (10b5-1 plan) | 45,000 | $15.68 | $706K | Jan 14, 2026 |
| Jan 13, 2026 | Daniel Dines | CEO and Chairman; director | Sale (10b5-1 plan) | 45,000 | $17.18 | $773K | Jan 13, 2026 |
| Jan 12, 2026 | Daniel Dines | CEO and Chairman; director | Sale (10b5-1 plan) | 45,000 | $16.61 | $747K | Jan 12, 2026 |
| Jan 9, 2026 | Daniel Dines | CEO and Chairman; director | Sale (10b5-1 plan) | 45,000 | $17.17 | $773K | Jan 9, 2026 |
| Jan 8, 2026 | Daniel Dines | CEO and Chairman; director | Sale (10b5-1 plan) | 45,000 | $17.49 | $787K | Jan 8, 2026 |
| Jan 7, 2026 | Daniel Dines | CEO and Chairman; director | Sale (10b5-1 plan) | 45,000 | $17.32 | $779K | Jan 7, 2026 |
| Jan 6, 2026 | Daniel Dines | CEO and Chairman; director | Sale (10b5-1 plan) | 45,000 | $15.99 | $720K | Jan 6, 2026 |
| Jan 5, 2026 | Ashim Gupta | COO & CFO | Sale (10b5-1 plan) | 67,468 | $16.10 | $1.1M | Jan 6, 2026 |
| Jan 5, 2026 | Daniel Dines | CEO and Chairman; director | Sale (10b5-1 plan) | 45,000 | $15.73 | $708K | Jan 5, 2026 |
| Jan 2, 2026 | Daniel Dines | CEO and Chairman; director | Sale (10b5-1 plan) | 45,000 | $16.38 | $737K | Jan 2, 2026 |
| Dec 31, 2025 | Daniel Dines | CEO and Chairman; director | Sale (10b5-1 plan) | 45,000 | $16.55 | $745K | Dec 31, 2025 |
| Dec 30, 2025 | Daniel Dines | CEO and Chairman; director | Sale (10b5-1 plan) | 45,000 | $16.82 | $757K | Dec 31, 2025 |
| Dec 29, 2025 | Daniel Dines | CEO and Chairman; director | Sale (10b5-1 plan) | 45,000 | $16.44 | $740K | Dec 29, 2025 |
| Dec 26, 2025 | Daniel Dines | CEO and Chairman; director | Sale (10b5-1 plan) | 45,000 | $16.90 | $761K | Dec 29, 2025 |
| Dec 24, 2025 | Daniel Dines | CEO and Chairman; director | Sale (10b5-1 plan) | 45,000 | $16.91 | $761K | Dec 29, 2025 |
| Dec 23, 2025 | Daniel Dines | CEO and Chairman; director | Sale (10b5-1 plan) | 45,000 | $16.49 | $742K | Dec 23, 2025 |
| Dec 22, 2025 | Daniel Dines | CEO and Chairman; director | Sale (10b5-1 plan) | 45,000 | $16.49 | $742K | Dec 23, 2025 |
| Dec 17, 2025 | Daniel Dines | CEO and Chairman; director | Sale (10b5-1 plan) | 45,000 | $16.11 | $725K | Dec 17, 2025 |
| Dec 16, 2025 | Daniel Dines | CEO and Chairman; director | Sale (10b5-1 plan) | 45,000 | $16.26 | $732K | Dec 16, 2025 |
| Dec 15, 2025 | Daniel Dines | CEO and Chairman; director | Sale (10b5-1 plan) | 45,000 | $17.30 | $778K | Dec 15, 2025 |
| Dec 12, 2025 | Daniel Dines | CEO and Chairman; director | Sale (10b5-1 plan) | 45,000 | $17.91 | $806K | Dec 15, 2025 |
| Dec 11, 2025 | Daniel Dines | CEO and Chairman; director | Sale (10b5-1 plan) | 45,000 | $18.56 | $835K | Dec 11, 2025 |
| Dec 10, 2025 | Daniel Dines | CEO and Chairman; director | Sale (10b5-1 plan) | 45,000 | $18.61 | $837K | Dec 10, 2025 |
| Dec 9, 2025 | Daniel Dines | CEO and Chairman; director | Sale (10b5-1 plan) | 45,000 | $19.13 | $861K | Dec 9, 2025 |
| Dec 8, 2025 | Daniel Dines | CEO and Chairman; director | Sale (10b5-1 plan) | 45,000 | $19.21 | $865K | Dec 8, 2025 |
| Dec 5, 2025 | Brad Brubaker | GC & Chief Legal Officer | Sale (10b5-1 plan) | 27,580 | $18.55 | $512K | Dec 8, 2025 |
| Dec 5, 2025 | Daniel Dines | CEO and Chairman; director | Sale (10b5-1 plan) | 45,000 | $18.20 | $819K | Dec 5, 2025 |
From the Form 4s filed with the SEC about UiPath, Inc. (70 in the 12 months): purchases (code P) and sales (code S) on the open market by its officers and directors, at the price each filing gives (often an average of the day's trades). A sale is a 10b5-1 sale when its filing says it was made under such a plan, set up in advance. Not counted: 55 other transactions (grants, shares withheld for tax and other transfers).